C. Michael Gibson and Azeem Latib take a closer look at some next-gen TAVR devices.

C. Michael Gibson and Junjie Zhang discuss ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population.

C. Michael Gibson and William Fearon talk FFR-CT.

C. Michael Gibson and Holger Thiele take a deep dive into a head-to-head trial of TAVR devices that also considered general versus local anesthesia.

C. Michael Gibson talks with Patrick Serruys about TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population.

C. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.

C. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.

Does timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.

C. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.

C. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.